首页 > 最新文献

Surgery Today最新文献

英文 中文
The preoperative main body composition scoring system as a strong predictor of colorectal liver metastases. 术前主体成分评分系统作为结直肠肝转移的一个强有力的预测指标。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-04-01 Epub Date: 2025-11-02 DOI: 10.1007/s00595-025-03145-4
Kenei Furukawa, Teppei Kamada, Koichiro Haruki, Yoshihiro Shirai, Masashi Tsunematsu, Shinji Onda, Michinori Matsumoto, Tomohiko Taniai, Mitsuru Yanagaki, Toru Ikegami

Purposes: The three main components of body composition: skeletal muscle, adipose tissue, and bone, have been associated with cancer outcomes individually, but an integrative assessment combining all three has not been carried out. We aimed to establish a body composition scoring system incorporating all three components to stratify prognosis following hepatic resection for colorectal liver metastases (CRLM).

Methods: The subjects of this retrospective study were 164 patients who underwent hepatic resection for CRLM. The skeletal muscle index (SMI), fat area, and bone mineral density (BMD) were quantified using preoperative computed tomography (CT). A main body composition score (0-3) was developed by assigning 1 point for each high-value component. Patients were stratified into three groups according to their score: low (0), medium (1), and high (2-3).

Results: The main body composition score correlated significantly with disease-free survival and overall survival (OS). The 5-year OS rate was 27.1% in the low-score group, 62.1% in the medium-score group, and 70.6% in the high-score group (p < 0.01). In the multivariable analysis, a low main body composition score predicted poor OS independently (hazard ratio, 3.18; 95% confidence interval, 1.68-6.03; p < 0.01).

Conclusion: The main body composition score, incorporating the SMI, fat area, and BMD, effectively stratified the survival outcomes of patients undergoing hepatic resection for CRLM.

目的:人体组成的三个主要组成部分:骨骼肌、脂肪组织和骨骼分别与癌症结局相关,但尚未进行将三者结合起来的综合评估。我们的目的是建立一个包含所有三个组成部分的身体成分评分系统,以对结肠直肠癌肝转移(CRLM)肝切除术后的预后进行分层。方法:本回顾性研究的对象是164例肝切除术治疗CRLM的患者。使用术前计算机断层扫描(CT)对骨骼肌指数(SMI)、脂肪面积和骨密度(BMD)进行量化。主体成分评分(0-3分),每个高值成分评分1分。患者根据评分分为低(0)、中(1)、高(2-3)三组。结果:主体成分评分与无病生存期和总生存期(OS)显著相关。低评分组的5年OS率为27.1%,中评分组为62.1%,高评分组为70.6% (p)。结论:结合SMI、脂肪面积、骨密度的主体组成评分可以有效地对肝切除CRLM患者的生存结果进行分层。
{"title":"The preoperative main body composition scoring system as a strong predictor of colorectal liver metastases.","authors":"Kenei Furukawa, Teppei Kamada, Koichiro Haruki, Yoshihiro Shirai, Masashi Tsunematsu, Shinji Onda, Michinori Matsumoto, Tomohiko Taniai, Mitsuru Yanagaki, Toru Ikegami","doi":"10.1007/s00595-025-03145-4","DOIUrl":"10.1007/s00595-025-03145-4","url":null,"abstract":"<p><strong>Purposes: </strong>The three main components of body composition: skeletal muscle, adipose tissue, and bone, have been associated with cancer outcomes individually, but an integrative assessment combining all three has not been carried out. We aimed to establish a body composition scoring system incorporating all three components to stratify prognosis following hepatic resection for colorectal liver metastases (CRLM).</p><p><strong>Methods: </strong>The subjects of this retrospective study were 164 patients who underwent hepatic resection for CRLM. The skeletal muscle index (SMI), fat area, and bone mineral density (BMD) were quantified using preoperative computed tomography (CT). A main body composition score (0-3) was developed by assigning 1 point for each high-value component. Patients were stratified into three groups according to their score: low (0), medium (1), and high (2-3).</p><p><strong>Results: </strong>The main body composition score correlated significantly with disease-free survival and overall survival (OS). The 5-year OS rate was 27.1% in the low-score group, 62.1% in the medium-score group, and 70.6% in the high-score group (p < 0.01). In the multivariable analysis, a low main body composition score predicted poor OS independently (hazard ratio, 3.18; 95% confidence interval, 1.68-6.03; p < 0.01).</p><p><strong>Conclusion: </strong>The main body composition score, incorporating the SMI, fat area, and BMD, effectively stratified the survival outcomes of patients undergoing hepatic resection for CRLM.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"488-495"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145426979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Umbilical fat is useful for evaluating the risk of incisional hernia after laparoscopic colorectal surgery. 脐脂肪对于评估腹腔镜结直肠手术后切口疝的风险是有用的。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-04-01 Epub Date: 2025-11-04 DOI: 10.1007/s00595-025-03150-7
Chika Katayama, Yasuaki Enokida, Takuya Shiraishi, Yuta Shibasaki, Takuhisa Okada, Katsuya Osone, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Ken Shirabe, Hiroshi Saeki

Purpose: To investigate the risk factors for incisional hernia (IH) in colorectal cancer patients treated with laparoscopic surgery and midline laparotomy.

Methods: We retrospectively reviewed 140 patients with colorectal cancer and examined their risk factors for IH. We analyzed the clinical findings and associations between these factors and the incidence of IH using Cox proportional hazards models. In particular, we considered umbilical fat.

Results: The cumulative incidence of IH was 33.6% (47 patients), with three symptomatic patients (2.1%). In a multivariate proportional hazard analysis, umbilical fat (p < 0.01; hazard ratio, 6.56; 95% confidence interval, 2.73-15.70) and intermittent suturing with polyglycolic acid (p < 0.01; hazard ratio, 3.56; 95% confidence interval, 1.43-8.87) were significant risk factors for IH. Additionally, long operative times and adjuvant chemotherapy were associated with a high risk of IH in patients with running sutures for abdominal midline incisions.

Conclusion: Umbilical fat may be a significant risk factor for IH after laparoscopic colorectal surgery. Preoperative computed tomography is useful for assessing umbilical fat and identifying high-risk patients. Short-pitch running sutures performed for abdominal closure using a slowly absorbable monofilament suture material within a controlled operative time are essential for preventing IH.

目的:探讨腹腔镜手术加剖腹中线手术治疗结直肠癌患者发生切口疝的危险因素。方法:回顾性分析140例结直肠癌患者的IH危险因素。我们使用Cox比例风险模型分析了临床表现以及这些因素与IH发生率之间的关系。我们特别考虑了脐带脂肪。结果:IH累计发病率为33.6%(47例),有症状者3例(2.1%)。结论:脐带脂肪可能是腹腔镜结直肠手术后IH的重要危险因素。术前计算机断层扫描对评估脐带脂肪和识别高危患者是有用的。在控制的手术时间内,使用可缓慢吸收的单丝缝合材料进行短间距的腹部缝合对于预防IH至关重要。
{"title":"Umbilical fat is useful for evaluating the risk of incisional hernia after laparoscopic colorectal surgery.","authors":"Chika Katayama, Yasuaki Enokida, Takuya Shiraishi, Yuta Shibasaki, Takuhisa Okada, Katsuya Osone, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Ken Shirabe, Hiroshi Saeki","doi":"10.1007/s00595-025-03150-7","DOIUrl":"10.1007/s00595-025-03150-7","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the risk factors for incisional hernia (IH) in colorectal cancer patients treated with laparoscopic surgery and midline laparotomy.</p><p><strong>Methods: </strong>We retrospectively reviewed 140 patients with colorectal cancer and examined their risk factors for IH. We analyzed the clinical findings and associations between these factors and the incidence of IH using Cox proportional hazards models. In particular, we considered umbilical fat.</p><p><strong>Results: </strong>The cumulative incidence of IH was 33.6% (47 patients), with three symptomatic patients (2.1%). In a multivariate proportional hazard analysis, umbilical fat (p < 0.01; hazard ratio, 6.56; 95% confidence interval, 2.73-15.70) and intermittent suturing with polyglycolic acid (p < 0.01; hazard ratio, 3.56; 95% confidence interval, 1.43-8.87) were significant risk factors for IH. Additionally, long operative times and adjuvant chemotherapy were associated with a high risk of IH in patients with running sutures for abdominal midline incisions.</p><p><strong>Conclusion: </strong>Umbilical fat may be a significant risk factor for IH after laparoscopic colorectal surgery. Preoperative computed tomography is useful for assessing umbilical fat and identifying high-risk patients. Short-pitch running sutures performed for abdominal closure using a slowly absorbable monofilament suture material within a controlled operative time are essential for preventing IH.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"496-506"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145438999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and treatment patterns of urachal remnants in adult patients with omphalitis: a nationwide claims-based study in Japan. 成人脐炎患者尿管残余的流行病学和治疗模式:日本一项全国性的基于索赔的研究。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-04-01 Epub Date: 2025-10-15 DOI: 10.1007/s00595-025-03151-6
Ryota Tokunaga, Takenori Yamauchi, Hiroki Den, Shunsuke Omotaka, Suguru Ogihara, Masayuki Isozaki, Takahiro Hobo, Noboru Yokoyama, Haruhiro Inoue, Akatsuki Kokaze

Purpose: Urachal remnants are common in neonates and can persist into adulthood. However, their epidemiology in adults remains poorly characterized. We aimed to investigate the prevalence and clinical features of urachal remnants in adult Japanese patients with omphalitis using a nationwide claims database.

Methods: We analyzed data from the Japan Medical Data Center Claims Database (2005-2023) to identify patients  ≥ 15 years of age who were diagnosed with omphalitis. The prevalence of urachal remnants, associated diagnoses, surgical interventions, and time to surgery was examined, focusing on sex differences and age distribution.

Results: Of the 11,477 patients with omphalitis, 1836 (16.0%) had urachal remnants, with a male-to-female ratio of 2.53:1. The prevalence peaked in males of 20-34 years of age, exceeding 30%. Surgical intervention was performed in 39.7% of the cases, with a median time to surgery of 2 months. The number of laparoscopic procedures increased after 2014 and surpassed that of open surgeries by 2018. One case of urachal cancer (0.054%) was also identified.

Conclusion: Urachal remnants are relatively common in adults with omphalitis, particularly in young males, and usually require surgery. Given the high prevalence and risk of recurrence, early imaging should be considered in adult omphalitis cases to support a timely diagnosis and intervention.

目的:乌拉恰尔残余在新生儿中很常见,并可持续到成年。然而,它们在成人中的流行病学特征仍然很差。我们的目的是通过全国索赔数据库调查日本成人脐炎患者的尿路残余的患病率和临床特征。方法:我们分析来自日本医疗数据中心索赔数据库(2005-2023)的数据,以确定年龄≥15岁的诊断为脐炎的患者。检查尿路残余的患病率,相关诊断,手术干预和手术时间,重点是性别差异和年龄分布。结果:11477例脐炎患者中,尿管残余1836例(16.0%),男女比例为2.53:1。患病率在20-34岁男性中最高,超过30%。39.7%的病例行手术干预,中位手术时间为2个月。2014年之后,腹腔镜手术的数量有所增加,到2018年超过了开放式手术。尿管癌1例(0.054%)。结论:乌拉恰尔残余在成人脐炎中较为常见,尤其是年轻男性,通常需要手术治疗。鉴于成人脐炎的高患病率和复发风险,应考虑早期影像学检查,以支持及时诊断和干预。
{"title":"Epidemiology and treatment patterns of urachal remnants in adult patients with omphalitis: a nationwide claims-based study in Japan.","authors":"Ryota Tokunaga, Takenori Yamauchi, Hiroki Den, Shunsuke Omotaka, Suguru Ogihara, Masayuki Isozaki, Takahiro Hobo, Noboru Yokoyama, Haruhiro Inoue, Akatsuki Kokaze","doi":"10.1007/s00595-025-03151-6","DOIUrl":"10.1007/s00595-025-03151-6","url":null,"abstract":"<p><strong>Purpose: </strong>Urachal remnants are common in neonates and can persist into adulthood. However, their epidemiology in adults remains poorly characterized. We aimed to investigate the prevalence and clinical features of urachal remnants in adult Japanese patients with omphalitis using a nationwide claims database.</p><p><strong>Methods: </strong>We analyzed data from the Japan Medical Data Center Claims Database (2005-2023) to identify patients  ≥ 15 years of age who were diagnosed with omphalitis. The prevalence of urachal remnants, associated diagnoses, surgical interventions, and time to surgery was examined, focusing on sex differences and age distribution.</p><p><strong>Results: </strong>Of the 11,477 patients with omphalitis, 1836 (16.0%) had urachal remnants, with a male-to-female ratio of 2.53:1. The prevalence peaked in males of 20-34 years of age, exceeding 30%. Surgical intervention was performed in 39.7% of the cases, with a median time to surgery of 2 months. The number of laparoscopic procedures increased after 2014 and surpassed that of open surgeries by 2018. One case of urachal cancer (0.054%) was also identified.</p><p><strong>Conclusion: </strong>Urachal remnants are relatively common in adults with omphalitis, particularly in young males, and usually require surgery. Given the high prevalence and risk of recurrence, early imaging should be considered in adult omphalitis cases to support a timely diagnosis and intervention.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"436-444"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serial changes in pleural lavage cytology during lung cancer surgery predict recurrence and pleural dissemination. 肺癌手术期间胸膜灌洗细胞学的一系列变化预测复发和胸膜播散。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-04-01 Epub Date: 2025-10-17 DOI: 10.1007/s00595-025-03159-y
Go Kamimura, Masaya Aoki, Satomi Imamura, Shoichiro Morizono, Yuto Nonaka, Takuya Tokunaga, Aya Harada-Takeda, Koki Maeda, Toshiyuki Nagata, Kazuhiro Ueda

Purpose: Pleural lavage cytology (PLC) is a recognized prognostic marker in non-small cell lung cancer (NSCLC); however, the impact of serial intraoperative changes remains unclear.

Methods: We retrospectively analyzed 439 patients who underwent curative NSCLC resection. PLC was performed at three intraoperative points: after thoracotomy (pre-PLC), after lung resection, and after lavage at chest closure (post-PLC). Associations between recurrence-free survival (RFS) and pleural dissemination were evaluated by a Kaplan-Meier analysis and Fine and Gray competing risks regression.

Results: Forty-one patients had at least one positive PLC result. RFS was the lowest in pre-PLC( +)/post-PLC( +) (n = 10), intermediate in pre-PLC(-)/post-PLC( +) (n = 11), and best in post-PLC( -) (n = 20). Importantly, post-PLC( -) patients included 13 patients with pre-PLC positivity, yet their RFS matched that of consistently negative cases (n = 398). The cumulative incidence of pleural dissemination exhibited a similar pattern. In a multivariate analysis, post-PLC positivity, but not pre-PLC positivity, independently predicted poor RFS (hazard ratio, 3.06; p < 0.001).

Conclusion: Post-PLC, but not pre-PLC, provides decisive prognostic information for recurrence and pleural dissemination, likely reflecting residual lavage-resistant tumor clusters. Importantly, combining pre- and post-PLC results refines risk stratification and identifies the poorest-outcome subgroup that may benefit from adjuvant therapy.

目的:胸腔灌洗细胞学(PLC)是公认的非小细胞肺癌(NSCLC)预后指标;然而,术中一系列改变的影响尚不清楚。方法:我们回顾性分析了439例接受治愈性非小细胞肺癌切除术的患者。PLC在术中三个时间点进行:开胸后(PLC前)、肺切除后、闭胸灌洗后(PLC后)。通过Kaplan-Meier分析和Fine and Gray竞争风险回归评估无复发生存(RFS)与胸膜播散之间的关系。结果:41例患者至少有1例PLC阳性。RFS是最低的pre-PLC (+) / post-PLC (+) (n = 10),中间在pre-PLC (-) / post-PLC (+) (n = 11),和最佳的post-PLC (-) (n = 20)。重要的是,plc(-)后患者包括13例plc前阳性患者,但他们的RFS与持续阴性病例(n = 398)相匹配。胸膜播散的累积发病率表现出类似的模式。在多变量分析中,plc后阳性,而不是plc前阳性,独立预测不良RFS(风险比,3.06;p)结论:plc后,而不是plc前,为复发和胸膜播散提供了决定性的预后信息,可能反映了残留的耐灌洗肿瘤簇。重要的是,结合plc术前和术后的结果可以细化风险分层,并确定可能从辅助治疗中获益的预后最差的亚组。
{"title":"Serial changes in pleural lavage cytology during lung cancer surgery predict recurrence and pleural dissemination.","authors":"Go Kamimura, Masaya Aoki, Satomi Imamura, Shoichiro Morizono, Yuto Nonaka, Takuya Tokunaga, Aya Harada-Takeda, Koki Maeda, Toshiyuki Nagata, Kazuhiro Ueda","doi":"10.1007/s00595-025-03159-y","DOIUrl":"10.1007/s00595-025-03159-y","url":null,"abstract":"<p><strong>Purpose: </strong>Pleural lavage cytology (PLC) is a recognized prognostic marker in non-small cell lung cancer (NSCLC); however, the impact of serial intraoperative changes remains unclear.</p><p><strong>Methods: </strong>We retrospectively analyzed 439 patients who underwent curative NSCLC resection. PLC was performed at three intraoperative points: after thoracotomy (pre-PLC), after lung resection, and after lavage at chest closure (post-PLC). Associations between recurrence-free survival (RFS) and pleural dissemination were evaluated by a Kaplan-Meier analysis and Fine and Gray competing risks regression.</p><p><strong>Results: </strong>Forty-one patients had at least one positive PLC result. RFS was the lowest in pre-PLC( +)/post-PLC( +) (n = 10), intermediate in pre-PLC(-)/post-PLC( +) (n = 11), and best in post-PLC( -) (n = 20). Importantly, post-PLC( -) patients included 13 patients with pre-PLC positivity, yet their RFS matched that of consistently negative cases (n = 398). The cumulative incidence of pleural dissemination exhibited a similar pattern. In a multivariate analysis, post-PLC positivity, but not pre-PLC positivity, independently predicted poor RFS (hazard ratio, 3.06; p < 0.001).</p><p><strong>Conclusion: </strong>Post-PLC, but not pre-PLC, provides decisive prognostic information for recurrence and pleural dissemination, likely reflecting residual lavage-resistant tumor clusters. Importantly, combining pre- and post-PLC results refines risk stratification and identifies the poorest-outcome subgroup that may benefit from adjuvant therapy.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"455-461"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of stem cell transplantation in the treatment of anal fistula. 干细胞移植治疗肛瘘的研究进展。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-04-01 Epub Date: 2025-12-13 DOI: 10.1007/s00595-025-03177-w
XiaoJuan Chen, SiYu Yan

Stem cell transplantation has emerged as a promising therapeutic modality for the treatment of anal fistulas, showing significant potential in addressing this challenging condition. This review aims to summarize the latest research advancements in the field of stem cell therapy for anal fistula, focusing on the underlying mechanisms that contribute to healing, the clinical applications that have been explored in various studies, and the assessment of therapeutic efficacy. Despite these encouraging results, several issues remain, including the optimal source of stem cells, methods of administration, and long-term outcomes. The review will also discuss future research directions, emphasizing the need for standardized protocols and larger-scale clinical trials to establish the safety and effectiveness of stem cell transplantation in routine clinical practice.

干细胞移植已成为治疗肛瘘的一种有希望的治疗方式,在解决这一具有挑战性的疾病方面显示出巨大的潜力。本文综述了干细胞治疗肛瘘的最新研究进展,重点介绍了肛瘘愈合的潜在机制、各种研究探索的临床应用以及治疗效果的评估。尽管有这些令人鼓舞的结果,但仍存在一些问题,包括干细胞的最佳来源、给药方法和长期结果。综述还将讨论未来的研究方向,强调需要标准化的方案和更大规模的临床试验来建立干细胞移植在常规临床实践中的安全性和有效性。
{"title":"Research progress of stem cell transplantation in the treatment of anal fistula.","authors":"XiaoJuan Chen, SiYu Yan","doi":"10.1007/s00595-025-03177-w","DOIUrl":"10.1007/s00595-025-03177-w","url":null,"abstract":"<p><p>Stem cell transplantation has emerged as a promising therapeutic modality for the treatment of anal fistulas, showing significant potential in addressing this challenging condition. This review aims to summarize the latest research advancements in the field of stem cell therapy for anal fistula, focusing on the underlying mechanisms that contribute to healing, the clinical applications that have been explored in various studies, and the assessment of therapeutic efficacy. Despite these encouraging results, several issues remain, including the optimal source of stem cells, methods of administration, and long-term outcomes. The review will also discuss future research directions, emphasizing the need for standardized protocols and larger-scale clinical trials to establish the safety and effectiveness of stem cell transplantation in routine clinical practice.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"411-420"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145752234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic discrepancies between surgery-first and neoadjuvant-treated resected pancreatic cancer in the same pathological stage. 在同一病理阶段,手术先治和新辅助治疗切除的胰腺癌预后差异。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-04-01 Epub Date: 2025-11-06 DOI: 10.1007/s00595-025-03163-2
Suguru Yamada, Kenji Oshima, Kosuke Nomoto, Shotaro Sanada, Yukiko Oshima, Masafumi Ito, Akimasa Nakao

Purpose: To compare survival outcomes between patients undergoing upfront surgery and those receiving neoadjuvant therapy followed by surgery for pancreatic cancer stratified by pathological stage.

Methods: We retrospectively analyzed data from 456 patients who underwent curative-intent pancreatectomy between 2011 and 2023. The study patients were categorized into upfront surgery (n = 290) and neoadjuvant therapy (n = 166) groups. The overall and disease-free survival rates were compared between the groups within each pathological stage. Univariate and multivariate analyses were performed for patients with Stage I disease.

Results: In Stage IA, overall and disease-free survival were significantly better in the upfront surgery group than in the neoadjuvant therapy group (P = 0.0022 and P = 0.0012, respectively). There were no significant differences between the groups in patients with Stage II disease. A multivariate analysis of patients with Stage I disease identified neoadjuvant therapy (HR: 4.053, P = 0.0010), biliary drainage (HR: 2.342, P = 0.0399), and absence of adjuvant chemotherapy (HR: 4.563, P = 0.0004) as independent predictors of poor overall survival.

Conclusion: Even within the same pathological stage, the survival outcomes differed between the upfront surgery and neoadjuvant therapy groups. These findings suggest that treatment history should be considered when interpreting the pathological stage and assessing the prognosis of patients with pancreatic cancer.

目的:比较按病理分期进行胰腺癌术前和术后新辅助治疗患者的生存结局。方法:我们回顾性分析了2011年至2023年间456例接受治疗性胰腺切除术的患者的数据。研究患者分为前期手术组(290例)和新辅助治疗组(166例)。比较各组在各病理阶段的总生存率和无病生存率。对I期疾病患者进行单因素和多因素分析。结果:在IA期,前期手术组的总生存率和无病生存率明显优于新辅助治疗组(P = 0.0022和P = 0.0012)。在II期疾病患者中,两组间无显著差异。一项对I期疾病患者的多变量分析发现,新辅助治疗(HR: 4.053, P = 0.0010)、胆道引流(HR: 2.342, P = 0.0399)和缺乏辅助化疗(HR: 4.563, P = 0.0004)是总生存差的独立预测因素。结论:即使在同一病理阶段,术前治疗组和新辅助治疗组的生存结局也存在差异。这些结果提示,在解释胰腺癌患者的病理分期和评估预后时应考虑治疗史。
{"title":"Prognostic discrepancies between surgery-first and neoadjuvant-treated resected pancreatic cancer in the same pathological stage.","authors":"Suguru Yamada, Kenji Oshima, Kosuke Nomoto, Shotaro Sanada, Yukiko Oshima, Masafumi Ito, Akimasa Nakao","doi":"10.1007/s00595-025-03163-2","DOIUrl":"10.1007/s00595-025-03163-2","url":null,"abstract":"<p><strong>Purpose: </strong>To compare survival outcomes between patients undergoing upfront surgery and those receiving neoadjuvant therapy followed by surgery for pancreatic cancer stratified by pathological stage.</p><p><strong>Methods: </strong>We retrospectively analyzed data from 456 patients who underwent curative-intent pancreatectomy between 2011 and 2023. The study patients were categorized into upfront surgery (n = 290) and neoadjuvant therapy (n = 166) groups. The overall and disease-free survival rates were compared between the groups within each pathological stage. Univariate and multivariate analyses were performed for patients with Stage I disease.</p><p><strong>Results: </strong>In Stage IA, overall and disease-free survival were significantly better in the upfront surgery group than in the neoadjuvant therapy group (P = 0.0022 and P = 0.0012, respectively). There were no significant differences between the groups in patients with Stage II disease. A multivariate analysis of patients with Stage I disease identified neoadjuvant therapy (HR: 4.053, P = 0.0010), biliary drainage (HR: 2.342, P = 0.0399), and absence of adjuvant chemotherapy (HR: 4.563, P = 0.0004) as independent predictors of poor overall survival.</p><p><strong>Conclusion: </strong>Even within the same pathological stage, the survival outcomes differed between the upfront surgery and neoadjuvant therapy groups. These findings suggest that treatment history should be considered when interpreting the pathological stage and assessing the prognosis of patients with pancreatic cancer.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"515-524"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145453251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and outcomes of curative-intent surgery for clinically node-positive non-small cell lung cancer with interstitial lung disease. 临床淋巴结阳性非小细胞肺癌合并间质性肺疾病的治疗目的手术的可行性和结果
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-04-01 Epub Date: 2025-10-15 DOI: 10.1007/s00595-025-03154-3
Masatoshi Kanayama, Manabu Yasuda, Toshihiro Osaki, Hina Jojiki, Natsumasa Nishizawa, Yasuhiro Chikaishi, Fumihiro Tanaka

Purpose: This study aimed to evaluate the feasibility and outcomes of curative-intent surgery in patients with clinically node-positive non-small cell lung cancer (NCSLC) and interstitial lung disease (ILD).

Methods: We retrospectively evaluated patients with clinically node-positive NSCLC and ILD, who underwent curative-intent surgery between 2012 and 2022. Survival outcomes and complications were also assessed. Risk stratification for acute exacerbations of ILD (AE-ILD) was performed using the Japanese Association for Chest Surgery (JACS) score.

Results: Twenty-eight patients were included in the study. Postoperative AE-ILD developed in 17.9% of patients within 30 days and 25.0% within 90 days. The incidence was lower in the low-risk group than in the intermediate-risk group (30 days: 12.5 vs. 20.0%; 90 days: 12.5 vs. 30.0%). No ILD-related deaths occurred within one year postoperatively in the low-risk group, whereas 71.4% of the deaths in the intermediate-risk group were ILD-related. The median overall survival (OS) and recurrence-free survival (RFS) were 19.5 and 13.7 months, respectively. Patients with cN1 or cN2a had favorable outcomes (OS: 28.5 and 28.6 months; RFS: 13.7 and 28.6 months, respectively), whereas those with cN2b showed poor survival (OS/RFS: 2.4 months).

Conclusions: Curative-intent surgery may offer survival benefits for selected patients, particularly those with limited nodal disease and a low risk of AE-ILD.

目的:本研究旨在评估临床淋巴结阳性非小细胞肺癌(NCSLC)和间质性肺疾病(ILD)患者治疗目的手术的可行性和结果。方法:我们回顾性评估了临床淋巴结阳性的非小细胞肺癌和ILD患者,这些患者在2012年至2022年间接受了治疗目的手术。生存结果和并发症也进行了评估。使用日本胸外科协会(JACS)评分对ILD急性加重(AE-ILD)进行风险分层。结果:28例患者纳入研究。17.9%的患者术后30天内发生AE-ILD, 25.0%的患者术后90天内发生AE-ILD。低危组的发生率低于中危组(30天:12.5 vs. 20.0%; 90天:12.5 vs. 30.0%)。低危组术后一年内无ild相关死亡,而中危组71.4%的死亡与ild相关。中位总生存期(OS)和无复发生存期(RFS)分别为19.5和13.7个月。cN1或cN2a患者预后良好(生存期分别为28.5和28.6个月;RFS分别为13.7和28.6个月),而cN2b患者生存期较差(OS/RFS为2.4个月)。结论:以治愈为目的的手术可能为特定患者提供生存益处,特别是那些有限淋巴结疾病和AE-ILD低风险的患者。
{"title":"Feasibility and outcomes of curative-intent surgery for clinically node-positive non-small cell lung cancer with interstitial lung disease.","authors":"Masatoshi Kanayama, Manabu Yasuda, Toshihiro Osaki, Hina Jojiki, Natsumasa Nishizawa, Yasuhiro Chikaishi, Fumihiro Tanaka","doi":"10.1007/s00595-025-03154-3","DOIUrl":"10.1007/s00595-025-03154-3","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to evaluate the feasibility and outcomes of curative-intent surgery in patients with clinically node-positive non-small cell lung cancer (NCSLC) and interstitial lung disease (ILD).</p><p><strong>Methods: </strong>We retrospectively evaluated patients with clinically node-positive NSCLC and ILD, who underwent curative-intent surgery between 2012 and 2022. Survival outcomes and complications were also assessed. Risk stratification for acute exacerbations of ILD (AE-ILD) was performed using the Japanese Association for Chest Surgery (JACS) score.</p><p><strong>Results: </strong>Twenty-eight patients were included in the study. Postoperative AE-ILD developed in 17.9% of patients within 30 days and 25.0% within 90 days. The incidence was lower in the low-risk group than in the intermediate-risk group (30 days: 12.5 vs. 20.0%; 90 days: 12.5 vs. 30.0%). No ILD-related deaths occurred within one year postoperatively in the low-risk group, whereas 71.4% of the deaths in the intermediate-risk group were ILD-related. The median overall survival (OS) and recurrence-free survival (RFS) were 19.5 and 13.7 months, respectively. Patients with cN1 or cN2a had favorable outcomes (OS: 28.5 and 28.6 months; RFS: 13.7 and 28.6 months, respectively), whereas those with cN2b showed poor survival (OS/RFS: 2.4 months).</p><p><strong>Conclusions: </strong>Curative-intent surgery may offer survival benefits for selected patients, particularly those with limited nodal disease and a low risk of AE-ILD.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"445-454"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145303452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Montreal cognitive assessment domain-specific and clinical predictors of postoperative delirium in elderly gastrointestinal cancer patients. 蒙特利尔认知评估领域特异性和老年胃肠道肿瘤患者术后谵妄的临床预测因素。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-04-01 Epub Date: 2025-11-05 DOI: 10.1007/s00595-025-03171-2
Haruna Yamaguchi, Ryohei Kawabata, Shiori Yoshiyama, Mamiko Fujiwara, Norihisa Matsukawa, Masaru Kitamura, Tomohira Takeoka, Hisashi Hara, Terukazu Yoshihara, Akihiro Kitagawa, Hideo Tomihara, Atsushi Naito, Masahiro Murakami, Kazuhiro Shimomura, Shingo Noura, Atsushi Miyamoto

Purposes: Postoperative delirium (POD) is a serious complication in elderly patients undergoing gastrointestinal (GI) cancer surgery. This study aimed to identify the perioperative risk factors for POD, focusing on domain-specific cognitive function.

Methods: We retrospectively analyzed patients ≥ 65 years old who underwent GI cancer surgery and preoperative geriatric screening. POD was assessed using the Delirium Symptomatology Test. Cognitive domains were evaluated using the Japanese Montreal Cognitive Assessment (MoCA-J). A receiver operating characteristic (ROC) analysis identified the most predictive domain combination and compared its discriminative performance with that of conventional tools. Independent associations with POD were examined using Firth's logistic regression.

Results: Of 167 patients, 13 (7.8%) developed POD. The MoCA-J Memory + Orientation composite score showed the highest predictive accuracy. In the multivariable analysis, a composite score < 7 (odds ratio [OR] = 12.81, 95% confidence interval [CI]: 1.95-84.0), older age (per year, OR = 1.10, 95% CI: 1.01-1.21), preexisting respiratory disease (OR = 7.82, 95% CI: 1.40-43.9), and intraoperative blood loss (per 100 ml increment, OR = 1.53, 95% CI: 1.05-2.25) were independently associated with POD.

Conclusions: The MoCA-J domain-specific composite score for memory and orientation was the strongest predictor of POD, alongside established factors, such as older age, preexisting respiratory disease, and intraoperative blood loss.

目的:术后谵妄(POD)是老年胃肠癌手术患者的严重并发症。本研究旨在确定POD的围手术期危险因素,重点关注特定领域的认知功能。方法:我们回顾性分析≥65岁接受胃肠道肿瘤手术和术前老年筛查的患者。使用谵妄症状试验评估POD。认知领域采用日本蒙特利尔认知评估(MoCA-J)进行评估。接受者工作特征(ROC)分析确定了最具预测性的域组合,并将其判别性能与传统工具进行了比较。使用Firth逻辑回归检验与POD的独立关联。结果:167例患者中,13例(7.8%)发生POD。MoCA-J记忆+取向综合评分的预测准确率最高。结论:记忆和定向的MoCA-J结构域特异性综合评分与年龄、既往存在的呼吸系统疾病和术中失血等既定因素一起是POD的最强预测因子。
{"title":"Montreal cognitive assessment domain-specific and clinical predictors of postoperative delirium in elderly gastrointestinal cancer patients.","authors":"Haruna Yamaguchi, Ryohei Kawabata, Shiori Yoshiyama, Mamiko Fujiwara, Norihisa Matsukawa, Masaru Kitamura, Tomohira Takeoka, Hisashi Hara, Terukazu Yoshihara, Akihiro Kitagawa, Hideo Tomihara, Atsushi Naito, Masahiro Murakami, Kazuhiro Shimomura, Shingo Noura, Atsushi Miyamoto","doi":"10.1007/s00595-025-03171-2","DOIUrl":"10.1007/s00595-025-03171-2","url":null,"abstract":"<p><strong>Purposes: </strong>Postoperative delirium (POD) is a serious complication in elderly patients undergoing gastrointestinal (GI) cancer surgery. This study aimed to identify the perioperative risk factors for POD, focusing on domain-specific cognitive function.</p><p><strong>Methods: </strong>We retrospectively analyzed patients ≥ 65 years old who underwent GI cancer surgery and preoperative geriatric screening. POD was assessed using the Delirium Symptomatology Test. Cognitive domains were evaluated using the Japanese Montreal Cognitive Assessment (MoCA-J). A receiver operating characteristic (ROC) analysis identified the most predictive domain combination and compared its discriminative performance with that of conventional tools. Independent associations with POD were examined using Firth's logistic regression.</p><p><strong>Results: </strong>Of 167 patients, 13 (7.8%) developed POD. The MoCA-J Memory + Orientation composite score showed the highest predictive accuracy. In the multivariable analysis, a composite score < 7 (odds ratio [OR] = 12.81, 95% confidence interval [CI]: 1.95-84.0), older age (per year, OR = 1.10, 95% CI: 1.01-1.21), preexisting respiratory disease (OR = 7.82, 95% CI: 1.40-43.9), and intraoperative blood loss (per 100 ml increment, OR = 1.53, 95% CI: 1.05-2.25) were independently associated with POD.</p><p><strong>Conclusions: </strong>The MoCA-J domain-specific composite score for memory and orientation was the strongest predictor of POD, alongside established factors, such as older age, preexisting respiratory disease, and intraoperative blood loss.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"507-514"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145445920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RNA-binding motif protein 10 accelerates abdominal aortic aneurysm formation by inducing smooth muscle cell apoptosis. rna结合基序蛋白10通过诱导平滑肌细胞凋亡加速腹主动脉瘤形成。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-03-23 DOI: 10.1007/s00595-026-03280-6
Xiang-Yu Zhang, Huan-Huan Chen, Yue-Feng Zhu, Si-Yuan Hu, Huan Zhang, Ya-Xin Cui, Jin Yang, Chen-Yang Shen
{"title":"RNA-binding motif protein 10 accelerates abdominal aortic aneurysm formation by inducing smooth muscle cell apoptosis.","authors":"Xiang-Yu Zhang, Huan-Huan Chen, Yue-Feng Zhu, Si-Yuan Hu, Huan Zhang, Ya-Xin Cui, Jin Yang, Chen-Yang Shen","doi":"10.1007/s00595-026-03280-6","DOIUrl":"https://doi.org/10.1007/s00595-026-03280-6","url":null,"abstract":"","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147504886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for seroma formation after ALT flap harvest: a retrospective study focused on age and the fascia harvest area. ALT皮瓣摘取后血清肿形成的危险因素:年龄和筋膜摘取面积的回顾性研究。
IF 1.6 4区 医学 Q2 SURGERY Pub Date : 2026-03-19 DOI: 10.1007/s00595-026-03272-6
Kenji Tsuboi, Kento Yamamoto, Eisei Yoshizawa, Masashi Hayakawa, Hiroshi Furukawa
{"title":"Risk factors for seroma formation after ALT flap harvest: a retrospective study focused on age and the fascia harvest area.","authors":"Kenji Tsuboi, Kento Yamamoto, Eisei Yoshizawa, Masashi Hayakawa, Hiroshi Furukawa","doi":"10.1007/s00595-026-03272-6","DOIUrl":"https://doi.org/10.1007/s00595-026-03272-6","url":null,"abstract":"","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147487496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery Today
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1